Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2008

Conditions
Parkinson Disease
Interventions
DRUG

Pramipexole Extended Release

DRUG

Pramipexole Immediate Release

Trial Locations (36)

Unknown

248.636.3303A Boehringer Ingelheim Investigational Site, Aix-en-Provence

248.636.3303B Boehringer Ingelheim Investigational Site, Aix-en-Provence

248.636.3303C Boehringer Ingelheim Investigational Site, Aix-en-Provence

248.636.3307C Boehringer Ingelheim Investigational Site, Bron

248.636.3309B Boehringer Ingelheim Investigational Site, Clermont-Ferrand

248.636.3305A Boehringer Ingelheim Investigational Site, Créteil

248.636.3305B Boehringer Ingelheim Investigational Site, Créteil

248.636.3313A Boehringer Ingelheim Investigational Site, Dijon

248.636.3304A Boehringer Ingelheim Investigational Site, Évreux

248.636.3308B Boehringer Ingelheim Investigational Site, Lille

248.636.3308C Boehringer Ingelheim Investigational Site, Lille

248.636.3308D Boehringer Ingelheim Investigational Site, Lille

248.636.3308E Boehringer Ingelheim Investigational Site, Lille

248.636.3302A Boehringer Ingelheim Investigational Site, Marseille

248.636.3302B Boehringer Ingelheim Investigational Site, Marseille

248.636.3306B Boehringer Ingelheim Investigational Site, Montpellier

248.636.3312A Boehringer Ingelheim Investigational Site, Rouen

248.636.3312B Boehringer Ingelheim Investigational Site, Rouen

248.636.3311A Boehringer Ingelheim Investigational Site, Strasbourg

248.636.3301A Boehringer Ingelheim Investigational Site, Toulouse

248.636.3301B Boehringer Ingelheim Investigational Site, Toulouse

248.636.3301D Boehringer Ingelheim Investigational Site, Toulouse

248.636.49006 Boehringer Ingelheim Investigational Site, Achim Bei Bremen

248.636.49004 Boehringer Ingelheim Investigational Site, Berlin

248.636.49007 Boehringer Ingelheim Investigational Site, Berlin

248.636.49008 Boehringer Ingelheim Investigational Site, Berlin

248.636.49002 Boehringer Ingelheim Investigational Site, Gera

248.636.49001 Boehringer Ingelheim Investigational Site, Karlsruhe

248.636.49003 Boehringer Ingelheim Investigational Site, Steglitz

248.636.49005 Boehringer Ingelheim Investigational Site, Unterhaching

248.636.31005 Boehringer Ingelheim Investigational Site, 's-Hertogenbosch

248.636.31002 Boehringer Ingelheim Investigational Site, Geldrop

248.636.31003 Boehringer Ingelheim Investigational Site, Helmond

248.636.31006 Boehringer Ingelheim Investigational Site, Maastricht

248.636.31004 Boehringer Ingelheim Investigational Site, Nijmegen

248.636.31001 Boehringer Ingelheim Investigational Site, Sittard

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY